• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体电穿孔通过激活多功能和效应记忆 CD8 T 细胞增强疫苗介导的人乳头瘤病毒相关肿瘤的治疗控制。

In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8 T cells.

机构信息

Vaccine Development Laboratory, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Vaccine Development Laboratory, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

出版信息

Vaccine. 2017 Dec 19;35(52):7240-7249. doi: 10.1016/j.vaccine.2017.11.011. Epub 2017 Nov 22.

DOI:10.1016/j.vaccine.2017.11.011
PMID:29174677
Abstract

In vivo electroporation (EP) has reignited the clinical interest on DNA vaccines as immunotherapeutic approaches to control different types of cancer. EP has been associated with increased immune response potency, but its capacity in influencing immunomodulation remains unclear. Here we evaluated the impact of in vivo EP on the induction of cellular immune responses and therapeutic effects of a DNA vaccine targeting human papillomavirus-induced tumors. Our results demonstrate that association of EP with the conventional intramuscular administration route promoted a more efficient activation of multifunctional and effector memory CD8 T cells with enhanced cytotoxic activity. Furthermore, EP increased tumor infiltration of CD8 T cells and avoided tumor recurrences. Finally, our results demonstrated that EP promotes local migration of antigen presenting cells that enhances with vaccine co-delivery. Altogether the present evidences shed further light on the in vivo electroporation action and its impact on the immunogenicity of DNA vaccines.

摘要

体内电穿孔 (EP) 重新激发了人们对 DNA 疫苗作为控制不同类型癌症的免疫治疗方法的临床兴趣。EP 与增强免疫反应效力有关,但它影响免疫调节的能力尚不清楚。在这里,我们评估了体内 EP 对针对人乳头瘤病毒诱导肿瘤的 DNA 疫苗诱导细胞免疫反应和治疗效果的影响。我们的结果表明,EP 与常规的肌肉内给药途径联合使用可促进多功能和效应记忆 CD8 T 细胞的更有效激活,增强细胞毒性活性。此外,EP 增加了肿瘤浸润的 CD8 T 细胞并避免了肿瘤复发。最后,我们的结果表明,EP 促进了抗原呈递细胞的局部迁移,并且随着疫苗共递送而增强。总之,这些证据进一步阐明了体内电穿孔的作用及其对 DNA 疫苗免疫原性的影响。

相似文献

1
In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8 T cells.在体电穿孔通过激活多功能和效应记忆 CD8 T 细胞增强疫苗介导的人乳头瘤病毒相关肿瘤的治疗控制。
Vaccine. 2017 Dec 19;35(52):7240-7249. doi: 10.1016/j.vaccine.2017.11.011. Epub 2017 Nov 22.
2
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.与肌肉注射和皮内基因枪递送相比,通过电穿孔接种人乳头瘤病毒(HPV)DNA疫苗可引发最强的CD8 + T细胞免疫反应。
Vaccine. 2009 Sep 4;27(40):5450-9. doi: 10.1016/j.vaccine.2009.07.005. Epub 2009 Jul 19.
3
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.用HPV DNA疫苗初免后进行局部HPV重组痘苗病毒加强免疫可增强生殖道局部HPV特异性CD8 + T细胞介导的肿瘤控制。
Clin Cancer Res. 2016 Feb 1;22(3):657-69. doi: 10.1158/1078-0432.CCR-15-0234. Epub 2015 Sep 29.
4
Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.通过抗原工程和电穿孔实现人乳头瘤病毒(HPV)DNA疫苗诱导的CD8 + T细胞反应的最佳诱导及治疗性抗肿瘤效果。
Vaccine. 2009 Sep 25;27(42):5906-12. doi: 10.1016/j.vaccine.2009.07.033. Epub 2009 Aug 3.
5
Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.靶向人乳头瘤病毒诱导肿瘤的实验性 DNA 疫苗赋予的增强治疗效果。
Hum Gene Ther. 2013 Oct;24(10):861-70. doi: 10.1089/hum.2013.102.
6
Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors.经电穿孔的阴道内人乳头瘤病毒DNA疫苗接种可诱导局部CD8+ T细胞免疫反应以及针对宫颈阴道肿瘤的抗肿瘤作用。
Gene Ther. 2015 Jul;22(7):528-35. doi: 10.1038/gt.2015.17. Epub 2015 Mar 19.
7
Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.小家鼠乳头瘤病毒1感染的自发清除和疫苗诱导清除
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00699-17. Print 2017 Aug 1.
8
In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.在DNA-病毒样颗粒初免-加强免疫中进行体内电穿孔可优先增强HIV-1包膜特异性IgG2a、中和抗体及CD8 T细胞反应。
Vaccine. 2017 Apr 11;35(16):2042-2051. doi: 10.1016/j.vaccine.2017.03.006. Epub 2017 Mar 17.
9
Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.褪黑素通过抑制血管内皮生长因子(VEGF)表达及诱导CD8 + T细胞介导的抗肿瘤免疫来增强治疗性DNA疫苗的效力。
Arch Virol. 2018 Mar;163(3):587-597. doi: 10.1007/s00705-017-3647-z. Epub 2017 Nov 17.
10
Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control.电穿孔传递的人乳头瘤病毒 16 E7 DNA 疫苗的抗肿瘤治疗和抗转移活性:增强肿瘤控制的可能机制。
DNA Cell Biol. 2011 Dec;30(12):975-85. doi: 10.1089/dna.2011.1266. Epub 2011 Jun 7.

引用本文的文献

1
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges.用于人乳头瘤病毒相关癌症的治疗性疫苗:进展与挑战
Transl Cancer Res. 2022 Nov;11(11):3938-3940. doi: 10.21037/tcr-22-2158.
2
Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy.白细胞介素 6 和吲哚胺 2,3-双加氧酶作为与乳头瘤病毒相关肿瘤免疫治疗的潜在辅助靶点。
Front Immunol. 2022 Nov 3;13:1005937. doi: 10.3389/fimmu.2022.1005937. eCollection 2022.
3
Plasmid DNA for Therapeutic Applications in Cancer.
用于癌症治疗应用的质粒DNA。
Pharmaceutics. 2022 Sep 3;14(9):1861. doi: 10.3390/pharmaceutics14091861.
4
Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials.治疗性 HPV 相关恶性肿瘤 DNA 疫苗:临床试验的有前途的线索。
Viruses. 2022 Jan 25;14(2):239. doi: 10.3390/v14020239.
5
Enhanced Immune Responses and Protective Immunity to Zika Virus Induced by a DNA Vaccine Encoding a Chimeric NS1 Fused With Type 1 Herpes Virus gD Protein.编码与1型疱疹病毒gD蛋白融合的嵌合NS1的DNA疫苗诱导的针对寨卡病毒的增强免疫反应和保护性免疫
Front Med Technol. 2020 Dec 3;2:604160. doi: 10.3389/fmedt.2020.604160. eCollection 2020.
6
Active immunization combined with cisplatin confers enhanced therapeutic protection and prevents relapses of HPV-induced tumors at different anatomical sites.主动免疫联合顺铂可增强治疗保护作用,预防 HPV 诱导的不同解剖部位肿瘤的复发。
Int J Biol Sci. 2022 Jan 1;18(1):15-29. doi: 10.7150/ijbs.56644. eCollection 2022.
7
A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model.一种治疗性 DNA 疫苗和吉西他滨在临床前模型中协同作用,根除 HPV 相关肿瘤。
Oncoimmunology. 2021 Jul 25;10(1):1949896. doi: 10.1080/2162402X.2021.1949896. eCollection 2021.
8
Children From the Age of Three Show a Developmental Switch in T-Cell Differentiation.三岁儿童的 T 细胞分化显示出发育转变。
Front Immunol. 2020 Jul 28;11:1640. doi: 10.3389/fimmu.2020.01640. eCollection 2020.
9
Cytoskeletal Disruption after Electroporation and Its Significance to Pulsed Electric Field Therapies.电穿孔后的细胞骨架破坏及其对脉冲电场疗法的意义。
Cancers (Basel). 2020 Apr 30;12(5):1132. doi: 10.3390/cancers12051132.
10
Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model.表达一种可溶性白细胞介素-10 受体可增强一种与乳头瘤病毒相关的抗肿瘤疫苗在小鼠模型中的治疗效果。
Cancer Immunol Immunother. 2019 May;68(5):753-763. doi: 10.1007/s00262-018-02297-2. Epub 2019 Feb 26.